Gastrointestinal Cancer Excellence Forum

Gastrointestinal Cancer

Excellence Forum

Leaders in the field sharing authoritative insights and institutional best practices.

Novel Targeted Therapies a Possibility With Discovery of Enzymes Tied to Colon Cancer Tumor Growth

03/14/2019

Guodong Zhang, PhD, discusses the basis for and findings of his team’s research, which identified targetable enzymes linked to colon cancer tumor growth.

Guodong Zhang, PhD, discusses...

03/14/2019

Oncology

Interview

A New Target in Gastric Cancer Paves the Way for Promising Novel Therapies

02/06/2019

Toby Phesse, PhD, talks about new data he and his colleagues uncovered that could lead to the development of promising novel therapies in gastric cancer.

Toby Phesse, PhD, talks about...

02/06/2019

Oncology

Videos

New Therapy for Metastatic Gastric and Gastroesophageal Cancers

08/01/2018

Josep Tabernero, MD, PhD, summarizes the overall survival results from the TAGS study of trifluridine/tipiracil vs placebo in patients with metastatic gastric cancer refractory to standard therapies.

Josep Tabernero, MD, PhD,...

08/01/2018

Oncology

Videos

Using Biomarkers to Select Optimal Therapy in Pancreatic Cancer

07/10/2018

Eileen M O'Reilly, MD, discusses the value of using biomarkers to guide treatment selection for patients with pancreatic cancer.

Eileen M O'Reilly, MD, discusses...

07/10/2018

Oncology

Videos

The Future of Immunotherapy in Pancreatic Cancer

07/10/2018

Eileen M O'Reilly, MD, discusses the current landscape of immunotherapies for pancreatic cancer.

Eileen M O'Reilly, MD, discusses...

07/10/2018

Oncology

Videos

Current Evidence Supports Adjuvant Therapy for Patients With Pancreatic Cancer

07/10/2018

Thierry Conroy, MD, discusses the current evidence supporting adjuvant therapy for patients with pancreatic cancer, the anticipated impact of a new trial presented supporting mFOLFIRINOX for adjuvant therapy in resected patients, and how...

Thierry Conroy, MD, discusses...

07/10/2018

Oncology

Videos

Clinical Trial Results Raise Questions About Role of the Alpha-Fetoprotein in Hepatocellular Carcinoma

07/10/2018

Ghassan K Abou-Alfa, MD, shares his thoughts on a presentation given by Andrew X Zhu, MD, at the 2018 ESMO World Congress on Gastrointestinal Cancer on REACH and REACH-2 clinical trial data for ramucirumab as treatment in hepatocellular...

Ghassan K Abou-Alfa, MD, shares...

07/10/2018

Oncology

Videos

Despite Advances, Challenges Remain in the Treatment of Hepatocellular Carcinoma

07/10/2018

Ghassan K Abou-Alfa, MD, medical oncologist at the Memorial Sloan Kettering Cancer Center (New York, NY), discusses the biggest challenges that remain for the treatment of hepatocellular carcinoma.

Ghassan K Abou-Alfa, MD, medical...

07/10/2018

Oncology

Videos

New Agents Making a Positive Impact in the Treatment of Hepatocellular Carcinoma

07/10/2018

Ghassan K Abou-Alfa, MD, medical oncologist at the Memorial Sloan Kettering Cancer Center (New York, NY), discusses a few of the newer agents available for the treatment of hepatocellular carcinoma, and how these agents have impacted practice.

Ghassan K Abou-Alfa, MD, medical...

07/10/2018

Oncology

Videos

Atezolizumab Combination is Not Superior to Standard of Care for Chemotherapy-Refractory Metastatic Colorectal Cancer

07/07/2018

Josep Tabanero, MD, discusses the results of the phase 3 IMblaze70 trial comparing atezolizumab plus cobimetinib and atezolizumab monotherapy versus standard-of-care regorafenib in chemotherapy-refractory metastatic colorectal cancer.

Josep Tabanero, MD, discusses...

07/07/2018

Oncology

Section Editor

Ghassan Abou-Alfa, MD, MBA

Memorial Sloan Kettering Cancer Center, New York

Gastrointestinal Cancer Excellence Forum

Section Editor

Resources

Specialties

Events

Year Round Education

HMP Global Products